Publication | Open Access

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Diabetes ManagementCardiovascular DiseaseHealth PolicyDiabetesSecondary PreventionClinical TrialsType 2Diabetes MellitusPublic HealthMicrovascular DysfunctionMedicineMacrovascular EventsAtherosclerosis